Image 1 of 1
Image 1 of 1
Image 1 of 1
Image 1 of 1
Retatrutide (LY3437943) is a 39-amino-acid synthetic peptide derived from a GIP backbone, featuring non-coded residues and a C20 fatty diacid conjugation for extended stability and albumin binding. It functions as a balanced agonist at glucagon (GCGR) and glucagon-like peptide-1 (GLP-1R) receptors, with enhanced potency at the glucose-dependent insulinotropic polypeptide receptor (GIPR) in in vitro assays.
This 10mg vial is supplied exclusively for laboratory research purposes, strictly for non-clinical, in vitro, and experimental research applications. No medical, physiological, therapeutic, or diagnostic claims are made or implied.
Retatrutide (LY3437943) is a 39-amino-acid synthetic peptide derived from a GIP backbone, featuring non-coded residues and a C20 fatty diacid conjugation for extended stability and albumin binding. It functions as a balanced agonist at glucagon (GCGR) and glucagon-like peptide-1 (GLP-1R) receptors, with enhanced potency at the glucose-dependent insulinotropic polypeptide receptor (GIPR) in in vitro assays.
This 10mg vial is supplied exclusively for laboratory research purposes, strictly for non-clinical, in vitro, and experimental research applications. No medical, physiological, therapeutic, or diagnostic claims are made or implied.